Advertisement
Advertisement
PODD
Insulet Corporation
241.94
USDSponsored
-1.21
-0.50%
Feb 06, 16:00 UTC -5
Closed
After-Market
241.94
0.00
0.00%
PODD Earnings Reports
Positive Surprise Ratio
PODD beat 27 of 40 last estimates.
68%
Next Report
Date of Next Report
Feb 18, 2026
Estimate for Q4 25 (Revenue/ EPS)
$784.07M
/$1.47
Implied change from Q3 25 (Revenue/ EPS)
+11.01%
/+18.55%
Implied change from Q4 24 (Revenue/ EPS)
+31.22%
/+28.95%
Insulet Corporation earnings per share and revenue
On Nov 06, 2025, PODD reported earnings of 1.24 USD per share (EPS) for Q3 25, beating the estimate of 1.16 USD, resulting in a 6.50% surprise. Revenue reached 706.30 million, compared to an expected 690.26 million, with a 2.32% difference. The market reacted with a +2.85% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 26 analysts forecast an EPS of 1.47 USD, with revenue projected to reach 784.07 million USD, implying an increase of 18.55% EPS, and increase of 11.01% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
FAQ
What were Insulet Corporation's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Insulet Corporation reported EPS of $1.24, beating estimates by 6.5%, and revenue of $706.30M, 2.32% above expectations.
How did the market react to Insulet Corporation's Q3 2025 earnings?
The stock price moved up 2.85%, changed from $314.44 before the earnings release to $323.40 the day after.
When is Insulet Corporation expected to report next?
The next earning report is scheduled for Feb 18, 2026.
What are the forecasts for Insulet Corporation's next earnings report?
Based on 26
analysts, Insulet Corporation is expected to report EPS of $1.47 and revenue of $784.07M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement